Research group at the Tyndall National Institute got an article published on the use of up-converting nanoparticles
A research group at the Tyndall National Institute in Cork, Ireland, got an article published in Biomedical Optics Express titled "High contrast breast cancer biomarker semi-quantification and immunohistochemistry imaging using upconverting nanoparticles". The research study uses Lumito's technology with up-converting nanoparticles (UCNPs). The article examines the use of UCNPs to distinguish different levels of HER2 […]
Lumito attends the Digital Pathology & AI Congress in London
On December 7–8, Lumito will exhibit with a booth at the annual Digital Pathology & AI Congress in London. The presence is part of the company's branding work within the company's primary target group ahead of the upcoming launch of SCIZYS. – It is important for us to build trust around our brand and product. […]
Lumito has started an internal pilot study for multiplexing
Lumito has started a pilot study where the aim is to investigate the possibilities of multiplexing by adding another nanoparticle label to the company's unique UCNP-based technology. There is a pronounced need from the market regarding requests for multiplexing to facilitate further and streamline the work within tissue analysis. Lumito already offers multiplexing with today's […]
First factory produced SCIZYS reagent kit is now available
The first batch of Lumito's reagent intended for end customer sales is now produced by Lumito's production partner, Uniogen Oy. Lumito has collaborated with Uniogen Oy (formerly Kaivogen Oy) for over 15 months to prepare the production of the nanoparticle-based reagent kit belonging to the company's digital pathology solution. – It feels great that a […]
Dr. Gopalakrishnan and Lumito’s poster receives third place at R&D Summit: Institutes for Excellence Launch at UHCW NHS Trust
Friday September 15th, Lumito was awarded third place in a poster competition during the R&D Summit at the UHCW NHS Trust. The poster, entitled "Utility of Upconversion Nanoparticles (UCNP) Based Immunohistochemistry in Diagnostic Renal Biopsies – A Proof of Concept Study", is the poster presented in June at the Liverpool Pathology 2023 congress by Dr. […]
Successful presence for Lumito at the European Congress of Pathology
Lumito exhibited with a booth at the European Congress of Pathology in Dublin on September 10–12. The congress gathered a total of 4,448 people, and the interest in Lumito's booth was excellent. An increased interest was also shown from repeat visitors and potential distributors. The European Congress of Pathology ranks as one of Europe's leading […]
Lumito signs an agreement with Uniogen Oy
Lumito AB and the Finnish company Uniogen Oy have signed a cooperation agreement for the production of Lumito’s immunohistochemical reagent kit, SCIZYS Erbium Kit. The reagent kit is part of Lumito’s product offering and is based on upconverted nanoparticles. Since June 2022, Lumito has had a Letter of Intent in place with Uniogen Oy (formerly […]
The Promising Results from Lumito’s First International Pilot Study Were Presented at Liverpool Pathology 2023
The results from Lumito's first international pilot study show that it is possible to detect the deposition of immunoglobulin and complement in renal tissue using Lumito's technology. The result confirms the expectations that the study was based around and demonstrates that Lumito's technology has the potential to be established in renal diagnostics. In May, Lumito's […]
Lumito attends the 19th European Congress on Digital Pathology in Budapest
Lumito is attending the 19th European Congress on Digital Pathology in Budapest, June 14th – 17th, 2023. Lumito's Project Manager, Krzysztof Krawczyk, is present with the company's CTO, Andreas Johansson. Krzysztof also gives a poster presentation. See attached picture from the first day. For further information, please contact: Mattias Lundin, CEO LumitoE-mail: ml@lumito.sePh: +46 76 868 […]
Lumito launches new website
Lumito has now launched a new website. The website is designed to better reflect Lumito's ongoing commercialisation phase, with a special focus on the SCIZYS product ahead of the upcoming product launch. Visit our new website here! For further information, please contact: Mattias Lundin, CEO LumitoE-mail: ml@lumito.sePh: +46 76 868 45 09 Lumito Lumito specialises in medical […]